What a fantastic start to 2020! We have been on stage with Google, Microsoft, Siemens, Roche, Bayer, AstraZeneca, Novartis, Janssen and many others, as we continue to drive the adoption of AI for life sciences in Europe and encourage pharma to leap ahead in the intelligence race. So what have we been up to?
As we enter a new decade, our belief in the the impact of Artificial intelligence (AI) is only getting stronger. Supporting the industry to drive the right drug to the right patient at speed is a huge responsibility that we take very seriously. Towards the end of the last decade we have seen great progress made within life sciences and the use of AI, but moving in to 2020 the spotlight on commercial teams and gaining competitive advantage with AI will intensify.